Gareth Morgan Investments Limited Partnership decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 79,028 shares of the healthcare conglomerate’s stock after selling 1,629 shares during the period. UnitedHealth Group comprises approximately 1.1% of Gareth Morgan Investments Limited Partnership’s investment portfolio, making the stock its 16th largest position. Gareth Morgan Investments Limited Partnership’s holdings in UnitedHealth Group were worth $12,961,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Retirement Systems of Alabama raised its position in UnitedHealth Group by 2.5% in the first quarter. Retirement Systems of Alabama now owns 640,240 shares of the healthcare conglomerate’s stock valued at $105,006,000 after buying an additional 15,403 shares in the last quarter. Honeywell International Inc. purchased a new position in UnitedHealth Group during the first quarter valued at $35,262,000. Baldwin Brothers Inc. MA raised its position in UnitedHealth Group by 20.7% in the first quarter. Baldwin Brothers Inc. MA now owns 1,249 shares of the healthcare conglomerate’s stock valued at $205,000 after buying an additional 214 shares in the last quarter. Harwood Advisory Group LLC raised its position in UnitedHealth Group by 0.8% in the first quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock valued at $309,000 after buying an additional 15 shares in the last quarter. Finally, Mn Services Vermogensbeheer B.V. raised its position in UnitedHealth Group by 3.9% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 25,730 shares of the healthcare conglomerate’s stock valued at $3,946,000 after buying an additional 970 shares in the last quarter. Institutional investors own 86.37% of the company’s stock.

Shares of UnitedHealth Group Incorporated (UNH) traded up 0.23% during trading on Friday, reaching $193.02. 2,210,720 shares of the company’s stock traded hands. The company has a market cap of $186.62 billion, a price-to-earnings ratio of 23.19 and a beta of 0.64. The company’s 50-day moving average is $189.36 and its 200 day moving average is $174.75. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.96 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

WARNING: This story was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/08/13/unitedhealth-group-incorporated-unh-stake-decreased-by-gareth-morgan-investments-limited-partnership.html.

UNH has been the topic of several recent analyst reports. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price objective on the stock in a research note on Monday, May 15th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 price objective on the stock in a research note on Tuesday, May 30th. BidaskClub upgraded shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 8th. Morgan Stanley upped their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, June 28th. Finally, Mizuho upped their price target on shares of UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a research note on Tuesday, April 18th. One investment analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $202.20.

In related news, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the transaction, the director now directly owns 75,735 shares in the company, valued at $13,832,240.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,540 shares of company stock valued at $2,873,320. Company insiders own 0.89% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.